The Veteran's death was caused by pulmonary thromboembolism, but the appellant argues that her service-connected hidradenitis suppurativa and prescribed medication contributed to it. The Board has ordered additional development including obtaining VA treatment records and a medical opinion.
The deciding factor: A new medical opinion is needed to determine if the Veteran's service-connected hidradenitis suppurativa, along with any prescribed medications, contributed substantially or materially to her death.
- Claimed conditions
- hidradenitis suppurativa
- How they argued it
- Secondary to another service-connected condition
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- February 25, 2021
- Citation
- 21010562
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 21010562.
What this means for you
A remand sends an issue back for more development, often a new examination or missing records. It does not award the benefit or decide the final outcome. The original decision explains the additional work ordered.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Denied
The Veteran's hidradenitis suppurativa is rated at 10 percent, which does not meet the criteria for a higher rating under VA regulations.,The Veteran's tension headaches do not meet the criteria for a compensable disability rating as there are no characteristic prostrating attacks averaging one in two months over the last several months.
- Whole decision: Granted
The Board has granted service connection for hidradenitis suppurativa, a cyst condition that the Veteran first experienced during active duty in 2008. The decision is based on the Veteran's competent lay testimony and medical evidence showing current disability and continuity of symptoms since service.
- Whole decision: Dismissed
The appeal regarding the denial of service connection for hidradenitis suppurativa, a bilateral armpit disability, in a June 2016 rating decision is dismissed due to procedural defects.
- Whole decision: Granted
The Veteran's hidradenitis suppurativa is granted a 60 percent disability rating, effective from the date of the decision. The claim for TDIU has been remanded.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.